CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Distal Extrahepatic Cholangiocarcinoma May Gain From Neoadjuvant Radiation]]>

Neutral
AI Analysis

Summary

Dr. Ethan B. Ludmir discusses which cholangiocarcinoma subsets based on tumor location may benefit most from neoadjuvant radiation therapy prior to surgery.

Importance:2/10
Sentiment:
0.00
cholangiocarcinomaneoadjuvant radiationoncologytreatment approach

Read the original article

Published by Cancer Network on September 28, 2026 3:00 PM

Read Original